These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 217183)

  • 21. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
    Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
    Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.
    Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B
    Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of DTIC in the malignant carcinoid syndrome.
    Kessinger A; Foley JF; Lemon HM
    Cancer Treat Rep; 1977; 61(1):101-2. PubMed ID: 861955
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
    Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY
    Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy-cum-irradiation in the treatment of inoperable small-cell and anaplastic large-cell bronchogenic carcinoma (author's transl)].
    Niederle N; Seeber S; Konietzko N; Schmidt CG
    Prax Klin Pneumol; 1980 Sep; 34(9):533-40. PubMed ID: 6256725
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung.
    Krauss S; Lowenbraun S; Bartolucci A; Buchanan R; Birch R
    Cancer Clin Trials; 1981; 4(2):147-53. PubMed ID: 6265109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
    Yokoyama A; Kinameri K; Kurita Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental studies at Southern Research Institute with DTIC (NSC-45388).
    Montgomery JA
    Cancer Treat Rep; 1976 Feb; 60(2):125-34. PubMed ID: 1260770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL
    Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term survival after pulmonary resection in bronchogenic carcinoma (author's transl)].
    Schlick W; Jenny H; Kuschan K
    Wien Klin Wochenschr; 1981 May; 93(10):325-8. PubMed ID: 6266164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical studies with DTIC (NSC-45388) in various malignancies.
    Slavik M
    Cancer Treat Rep; 1976 Feb; 60(2):213-4. PubMed ID: 769976
    [No Abstract]   [Full Text] [Related]  

  • 35. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of small cell bronchogenic carcinoma with VM-26.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DTIC (NSC-45388) studies in the southwest oncology group.
    Costanzi JJ
    Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
    Cox JD; Samson MK; Herskovic AM; Abrams R; Koehler M
    Cancer Treat Rep; 1986 Oct; 70(10):1219-20. PubMed ID: 3019546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of oral etoposide in small cell carcinoma of the lung].
    Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.